Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.855 USD | -4.52% | +8.28% | -31.84% |
02/05 | CUREVAC : A missed opportunity | |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.84% | 670M | |
+22.56% | 46.4B | |
-1.83% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.35% | 26.01B | |
-19.24% | 19.52B | |
+27.73% | 12.43B | |
0.00% | 12.18B | |
-0.80% | 12.13B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- German Patent Court Grants BioNTech's Nullity Action Against CureVac